Documents
Application Sponsors
ANDA 077161 | GLAND PHARMA LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 50MG/ML | 0 | AMIODARONE HYDROCHLORIDE | AMIODARONE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2005-04-20 | |
LABELING; Labeling | SUPPL | 3 | AP | 2008-08-22 | |
LABELING; Labeling | SUPPL | 4 | AP | 2009-01-15 | |
LABELING; Labeling | SUPPL | 5 | AP | 2009-11-20 | |
LABELING; Labeling | SUPPL | 6 | AP | 2010-07-30 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 2013-05-21 | |
LABELING; Labeling | SUPPL | 10 | AP | 2020-06-23 | STANDARD |
Submissions Property Types
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 7 | Null | 19 |
SUPPL | 10 | Null | 7 |
TE Codes
CDER Filings
GLAND PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 77161
[companyName] => GLAND PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"AMIODARONE HYDROCHLORIDE","activeIngredients":"AMIODARONE HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AMIODARONE HYDROCHLORIDE","submission":"AMIODARONE HYDROCHLORIDE","actionType":"50MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)